资讯

Ophthalmology Times17 小时
Ocugen’s IND amendment to begin phase 2/3 confirmatory trial of OCU410ST cleared by FDA
Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...
Ophthalmology Times18 小时
Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
Advanced autofluorescence reveals cellular pigment reservoirs with therapeutic potential at the Heidelberg 2025 International ...